Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry.

Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, Gray SW, Weitzel JN.

J Natl Cancer Inst. 2018 Apr 1. doi: 10.1093/jnci/djy027. [Epub ahead of print]

PMID:
29618041
2.

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.

Bradbury AR, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, Gulden C, Horte J, Long JM, Lucas T, Madaan S, Mattie K, McKenna D, Montgomery S, Nielsen S, Powers J, Rainey K, Rybak C, Savage M, Seelaus C, Stoll J, Stopfer JE, Yao XS.

J Natl Cancer Inst. 2018 Feb 27. doi: 10.1093/jnci/djy015. [Epub ahead of print]

PMID:
29490071
3.

Somatic TP53 variants frequently confound germ-line testing results.

Weitzel JN, Chao EC, Nehoray B, Van Tongeren LR, LaDuca H, Blazer KR, Slavin T, Facmg DABMD, Pesaran T, Rybak C, Solomon I, Niell-Swiller M, Dolinsky JS, Castillo D, Elliott A, Gau CL, Speare V, Jasperson K.

Genet Med. 2017 Nov 30. doi: 10.1038/gim.2017.196. [Epub ahead of print]

4.

Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.

Slavin T, Neuhausen SL, Rybak C, Solomon I, Nehoray B, Blazer K, Niell-Swiller M, Adamson AW, Yuan YC, Yang K, Sand S, Castillo D, Herzog J, Wu X, Tao S, Chavez T, Woo Y, Chao J, Mora P, Horcasitas D, Weitzel J.

Cancer Genet. 2017 Oct;216-217:111-119. doi: 10.1016/j.cancergen.2017.08.001. Epub 2017 Aug 17.

PMID:
29025585
5.

The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.

Slavin TP, Neuhausen SL, Nehoray B, Niell-Swiller M, Solomon I, Rybak C, Blazer K, Adamson A, Yang K, Sand S, Guerrero-Llamas N, Castillo D, Herzog J, Wu X, Tao S, Raja S, Chung V, Singh G, Nadesan S, Brown S, Cruz-Correa M, Petersen GM, Weitzel J; Clinical Cancer Genomics Community Research Network (CCGCRN).

Fam Cancer. 2018 Apr;17(2):235-245. doi: 10.1007/s10689-017-0019-5.

PMID:
28687971
6.

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN.

Front Oncol. 2015 Dec 2;5:271. doi: 10.3389/fonc.2015.00271. eCollection 2015.

7.

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN.

Front Oncol. 2015 Sep 29;5:208. doi: 10.3389/fonc.2015.00208. eCollection 2015. Erratum in: Front Oncol. 2015;5:271.

8.

Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.

Hall MJ, Innocent J, Rybak C, Veloski C, Scott WJ, Wu H, Ridge JA, Hoffman JP, Borghaei H, Turaka A, Daly MB.

Appl Clin Genet. 2015 Feb 17;8:69-73. doi: 10.2147/TACG.S72223. eCollection 2015.

9.

Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.

Patrick-Miller LJ, Egleston BL, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Albarracin J, Stevens E, Daly MB, Bradbury AR.

JMIR Res Protoc. 2014 Oct 29;3(4):e49. doi: 10.2196/resprot.3337.

10.

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.

Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, Rybak C, Mattie K, Brandt A, Chambers R, Chung WK, Churpek J, Daly MB, Digiovanni L, Farengo-Clark D, Fetzer D, Ganschow P, Grana G, Gulden C, Hall M, Kohler L, Maxwell K, Merrill S, Montgomery S, Mueller R, Nielsen S, Olopade O, Rainey K, Seelaus C, Nathanson KL, Domchek SM.

Genet Med. 2015 Jun;17(6):485-92. doi: 10.1038/gim.2014.134. Epub 2014 Oct 9.

11.

Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.

Matro JM, Ruth KJ, Wong YN, McCully KC, Rybak CM, Meropol NJ, Hall MJ.

J Genet Couns. 2014 Dec;23(6):1002-11. doi: 10.1007/s10897-014-9724-5. Epub 2014 May 6.

12.

Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.

Hall MJ, Herda MM, Handorf EA, Rybak CC, Keleher CA, Siemon M, Daly MB.

Genet Med. 2014 Nov;16(11):854-61. doi: 10.1038/gim.2014.42. Epub 2014 May 1.

13.

Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.

Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Bradbury AR.

Patient Educ Couns. 2013 Dec;93(3):413-9. doi: 10.1016/j.pec.2013.08.009. Epub 2013 Aug 19.

14.

Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6.

Adonizio C, Gazzillo M, Knezetic J, Snyder C, Lynch HT, Rybak C, Hall MJ, Lowstuter K, Eggington J, Morris GJ.

Semin Oncol. 2012 Apr;39(2):125-31. doi: 10.1053/j.seminoncol.2012.01.013. No abstract available.

PMID:
22484182
15.

Interpretation of genetic testing for lynch syndrome in patients with putative familial colorectal cancer.

Rybak C, Hall MJ.

J Natl Compr Canc Netw. 2011 Nov;9(11):1311-20. Review.

PMID:
22056658
16.

[Asking patients for their opinion, what is the change?!].

Caria A, Kergall A, Rybak C, Bloch J, Donio V, Marchand C.

Soins Psychiatr. 2001 Nov;(217):27-31. French. No abstract available.

PMID:
11949599
17.

[Accreditation. An admission strategy, a means of patient-centered care].

Rybak C.

Soins Psychiatr. 1999 Mar-Apr;(201):17-20. French. No abstract available.

PMID:
10693522
18.

Maple syrup urine disease variant: report on an infant.

Koepp P, Rybak C, Rüdiger HW, Wendel U.

Z Kinderheilkd. 1974 Feb 11;116(3):177-84. No abstract available.

PMID:
4813457
19.

Clinical finding and therapeutic problems in non-ketotic hyperglycinemia.

Koepp P, de Groot CJ, Grüttner R, Rybak C.

Helv Paediatr Acta. 1973 Nov;28(5):459-65. No abstract available.

PMID:
4773226
20.

[Hartnup disease (author's transl)].

Antener I, Bartelheimer HK, Grüttner R, Rybak C.

Monatsschr Kinderheilkd. 1973 Sep;121(9):571-83. German. No abstract available.

PMID:
4767088
21.

Short-term response of plasma amino acids to HGH.

Stahnke N, Menking M, Rybak C, Blunck W.

Acta Endocrinol Suppl (Copenh). 1973;173:98. No abstract available.

PMID:
4542151
22.

[Clinical problems of the genetic heterogeneity in hyperphenylalaninemias].

Grüttner R, Sternowsky HJ, Rybak C.

Monatsschr Kinderheilkd. 1971 Nov;119(11):600-4. German. No abstract available.

PMID:
5133646

Supplemental Content

Support Center